Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Garry, Ceccon"'
Autor:
Garry Ceccon, Michael Wollring, Anna Brunn, Martina Deckert, Dirk Waldschmidt, Gereon R. Fink, Norbert Galldiks
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 1, Pp 35-42 (2020)
Leptomeningeal carcinomatosis is an extremely rare, but devastating complication in pancreatic cancer patients with a poor prognosis despite multimodal treatment. We present a 51-year-old male patient with the very rare condition of leptomeningeal ca
Externí odkaz:
https://doaj.org/article/e8c63d5d898f4aa4bfe0d0670a112c59
Autor:
Philipp Lohmann, Martin Kocher, Garry Ceccon, Elena K. Bauer, Gabriele Stoffels, Shivakumar Viswanathan, Maximilian I. Ruge, Bernd Neumaier, Nadim J. Shah, Gereon R. Fink, Karl-Josef Langen, Norbert Galldiks
Publikováno v:
NeuroImage: Clinical, Vol 20, Iss , Pp 537-542 (2018)
Background: The aim of this study was to investigate the potential of combined textural feature analysis of contrast-enhanced MRI (CE-MRI) and static O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET for the differentiation between local recurrent brain me
Externí odkaz:
https://doaj.org/article/6f19c23d87994d338ea7d72a39e378e1
Autor:
Norbert Galldiks, Ulrich Herrlinger, Karl-Josef Langen, Gereon R. Fink, Gerrit H. Gielen, Christoph Kabbasch, Simone Marnitz, Eren Celik, Christian Baues, Gabriele Stoffels, Niklas Schäfer, Elena K. Bauer, Philipp Lohmann, Caroline Tscherpel, Christina Schaub, Garry Ceccon, Johannes Weller, Jan-Michael Werner
Purpose:The CeTeG/NOA-09 phase III trial demonstrated a significant survival benefit of lomustine–temozolomide chemoradiation in patients with newly diagnosed glioblastoma with methylated O6-methylguanine-DNA methyltransferase (MGMT) promoter. Foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd015f2ec7209eacf3a9d6eed62bc87a
https://doi.org/10.1158/1078-0432.c.6530673
https://doi.org/10.1158/1078-0432.c.6530673
Autor:
Norbert Galldiks, Ulrich Herrlinger, Karl-Josef Langen, Gereon R. Fink, Gerrit H. Gielen, Christoph Kabbasch, Simone Marnitz, Eren Celik, Christian Baues, Gabriele Stoffels, Niklas Schäfer, Elena K. Bauer, Philipp Lohmann, Caroline Tscherpel, Christina Schaub, Garry Ceccon, Johannes Weller, Jan-Michael Werner
Supplemental Figure 1 shows increase of time-to-peak supporting the diagnosis of pseudoprogression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8b4a87c5d272459da87cba4ac26d76
https://doi.org/10.1158/1078-0432.22481367.v1
https://doi.org/10.1158/1078-0432.22481367.v1
Autor:
Garry Ceccon, Philipp Lohmann, Erkan Celik, Christian Baues, Norbert Galldiks, Caroline Tscherpel, E K Bauer, Gereon R. Fink, Christoph Kabbasch, Gabriele Stoffels, Gerrit H. Gielen, Christina Schaub, Jan-Michael Werner, Johannes Weller, Ulrich Herrlinger, Karl-Josef Langen, Simone Marnitz, Niklas Schäfer
Publikováno v:
Clinical cancer research 27(13), 3704-3713 (2021). doi:10.1158/1078-0432.CCR-21-0471
Purpose: The CeTeG/NOA-09 phase III trial demonstrated a significant survival benefit of lomustine–temozolomide chemoradiation in patients with newly diagnosed glioblastoma with methylated O6-methylguanine-DNA methyltransferase (MGMT) promoter. Fol
Autor:
Alexander, Heinzel, Daniela, Dedic, Norbert, Galldiks, Philipp, Lohmann, Gabriele, Stoffels, Christian P, Filss, Martin, Kocher, Filippo, Migliorini, Kim N H, Dillen, Stefanie, Geisler, Carina, Stegmayr, Antje, Willuweit, Michael, Sabel, Marion, Rapp, Michael J, Eble, Marc, Piroth, Hans, Clusmann, Daniel, Delev, Elena K, Bauer, Garry, Ceccon, Veronika, Dunkl, Jurij, Rosen, Caroline, Tscherpel, Jan-Michael, Werner, Maximilian I, Ruge, Roland, Goldbrunner, Jürgen, Hampl, Carolin, Weiss Lucas, Ulrich, Herrlinger, Gabriele D, Maurer, Joachim P, Steinbach, Jörg, Mauler, Wieland A, Worthoff, Bernd N, Neumaier, Christoph, Lerche, Gereon R, Fink, Nadim Jon, Shah, Felix M, Mottaghy, Karl-Josef, Langen
Publikováno v:
Cancers. 14(14)
O-(2-[
Autor:
Jan-Michael Werner, Lena Wolf, Caroline Tscherpel, Elena K. Bauer, Michael Wollring, Garry Ceccon, Martina Deckert, Anna Brunn, Roberto Pappesch, Roland Goldbrunner, Gereon R. Fink, Norbert Galldiks
Publikováno v:
Journal of neuro-oncology 159(2), 309-317 (2022). doi:10.1007/s11060-022-04066-9
Background The phase 2 REGOMA trial suggested an encouraging overall survival benefit in glioblastoma patients at first relapse treated with the multikinase inhibitor regorafenib. Here, we evaluated the efficacy and side effects of regorafenib in a r
Autor:
Jurij, Rosen, Garry, Ceccon, Elena K, Bauer, Jan-Michael, Werner, Caroline, Tscherpel, Veronika, Dunkl, Marion, Rapp, Michael, Sabel, Ulrich, Herrlinger, Alexander, Heinzel, Niklas, Schäfer, Maximilian, Ruge, Roland, Goldbrunner, Gabriele, Stoffels, Christoph, Kabbasch, Gereon R, Fink, Karl-Josef, Langen, Norbert, Galldiks
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63(11)
In light of increasing health-care costs, higher medical expenses should be justified socioeconomically. Therefore, we calculated the effectiveness and cost effectiveness of PET using the radiolabeled amino acid
Autor:
Jurij Rosen, Garry Ceccon, Elena Katharina Bauer, Jan Michael Werner, Caroline Tscherpel, Veronika Dunkl, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Alexander Heinzel, Niklas Schaefer, Maximilian Ruge, Roland Goldbrunner, Gabriele Stoffels, Christoph Kabbasch, Gereon Rudolf Fink, Karl-Josef Langen, Norbert Galldiks
Publikováno v:
Journal of nuclear medicine 63(10), 1677-1682 (2022). doi:10.2967/jnumed.122.263790
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2742d9aa84a76210c14f9eac4f77bc0
https://juser.fz-juelich.de/record/910208
https://juser.fz-juelich.de/record/910208
Autor:
Michael M. Wollring, Jan-Michael Werner, Garry Ceccon, Philipp Lohmann, Christian P. Filss, Gereon R. Fink, Karl-Josef Langen, Norbert Galldiks
Publikováno v:
Journal of neuro-oncology 162, 481-488 (2023). doi:10.1007/s11060-022-04218-x special issue: "Special Issue: Diagnostic and Therapeutic Implications of IDH Mutations in Gliomas Following the 2021 World Health Organization Classification of CNS Tumors / Issue editors Tareq A. JuratliChristine JungkJulie J. Miller"
Journal of neuro-oncology 162, 481-488 (2023). doi:10.1007/s11060-022-04218-x
Journal of neuro-oncology 162, 481-488 (2023). doi:10.1007/s11060-022-04218-x
Journal of neuro-oncology (2022). doi:10.1007/s11060-022-04218-x
Published by Springer Science + Business Media B.V, Dordrecht [u.a.]
Published by Springer Science + Business Media B.V, Dordrecht [u.a.]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35473c9af141134d77f1e03270f43db0